Business Description
Endymed Ltd
NAICS : 334510
SIC : 3842
ISIN : IL0011010217
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 6.1 | |||||
Equity-to-Asset | 0.73 | |||||
Debt-to-Equity | 0.09 | |||||
Debt-to-EBITDA | -0.77 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 2.2 | |||||
Beneish M-Score | -2.28 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 16.5 | |||||
3-Year EBITDA Growth Rate | 23 | |||||
3-Year EPS without NRI Growth Rate | 20.3 | |||||
3-Year Book Growth Rate | 21.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 54.12 | |||||
9-Day RSI | 53.2 | |||||
14-Day RSI | 53.99 | |||||
6-1 Month Momentum % | 0.84 | |||||
12-1 Month Momentum % | 3.39 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.05 | |||||
Quick Ratio | 2.58 | |||||
Cash Ratio | 1.87 | |||||
Days Inventory | 205.04 | |||||
Days Sales Outstanding | 28.09 | |||||
Days Payable | 55.98 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | -0.18 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 46.26 | |||||
Operating Margin % | -10.73 | |||||
Net Margin % | -9.6 | |||||
FCF Margin % | -12.26 | |||||
ROE % | -12.44 | |||||
ROA % | -9.18 | |||||
ROIC % | -22.91 | |||||
ROC (Joel Greenblatt) % | -37.42 | |||||
ROCE % | -12.2 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.58 | |||||
PB Ratio | 0.85 | |||||
Price-to-Tangible-Book | 0.86 | |||||
EV-to-EBIT | -2.45 | |||||
EV-to-EBITDA | -3.21 | |||||
EV-to-Revenue | 0.25 | |||||
EV-to-FCF | -2.23 | |||||
Price-to-Projected-FCF | 0.71 | |||||
Price-to-Net-Current-Asset-Value | 1.11 | |||||
Price-to-Net-Cash | 5.61 | |||||
Earnings Yield (Greenblatt) % | -40.76 | |||||
FCF Yield % | -21.27 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Endymed Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₪) | 69.636 | ||
EPS (TTM) (₪) | -0.488 | ||
Beta | 0 | ||
Volatility % | 60.13 | ||
14-Day RSI | 53.99 | ||
14-Day ATR (₪) | 0.073943 | ||
20-Day SMA (₪) | 2.9032 | ||
12-1 Month Momentum % | 3.39 | ||
52-Week Range (₪) | 1.9 - 3.55 | ||
Shares Outstanding (Mil) | 13.76 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Endymed Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Endymed Ltd Stock Events
Event | Date | Price(₪) | ||
---|---|---|---|---|
No Event Data |
Endymed Ltd Frequently Asked Questions
What is Endymed Ltd(XTAE:ENDY)'s stock price today?
When is next earnings date of Endymed Ltd(XTAE:ENDY)?
Does Endymed Ltd(XTAE:ENDY) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |